Endoprostatic stents for management of benign prostatic hyperplasia.
Endoprostatic stents have been developed for relieving bladder outlet obstruction secondary to benign hyperplasia of the prostate. The stents are designed either for permanent or for temporary placement. The short-term temporary stents of various biostable and biodegradable polymers are needed after minimally invasive therapy of prostate with heat. The temporary stents are a management option, whereas the permanent stents are a treatment option. Permanent stents offer immediate relief and their sustained results for 4-7 years make them ideally suited for medically compromised patients.
Kapoor
R
R
Albert Einstein College of Medicine, Long Island Jewish Medical Center, Department of Urology, New York, NY 11042, USA.
Liatsikos
E N
EN
Badlani
G
G
D001672:Biocompatible Materials; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D015607:Stents; D014524:Urethral Obstruction / Q000628:therapy*
D001672:Biocompatible Materials